PAM
TGTX icon

Panagora Asset Management’s TG Therapeutics TGTX Stock Holding History

Panagora Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,044
Closed -$1.18M – 1213
2025
Q1 		$1.18M Sell
30,044
-130,598
-81% -$4.39M 0.01% 624
2024
Q4 		$4.84M Buy
160,642
+54,435
+51% +$1.56M 0.02% 347
2024
Q3 		$2.48M Buy
+106,207
New +$2.32M 0.01% 498
2022
Q1 		– Sell
-102,304
Closed -$1.94M – 1601
2021
Q4 		$1.94M Sell
102,304
-202,828
-66% -$5.27M 0.01% 659
2021
Q3 		$10.2M Sell
305,132
-74,862
-20% -$2.32M 0.05% 295
2021
Q2 		$14.7M Sell
379,994
-6,201
-2% -$244K 0.08% 230
2021
Q1 		$18.6M Buy
386,195
+163,202
+73% +$7.84M 0.1% 185
2020
Q4 		$11.6M Buy
+222,993
New +$7.53M 0.07% 248
2017
Q3 		– Sell
-83,229
Closed -$836K – 2484
2017
Q2 		$836K Hold
83,229
– – ﹤0.01% 1190
2017
Q1 		$970K Buy
+83,229
New +$597K ﹤0.01% 1154
2015
Q4 		– Sell
-12
Closed – – 2362
2015
Q3 		$0 Sell
12
-28,771
-100% -$429K ﹤0.01% 2421
2015
Q2 		$478K Buy
+28,783
New +$456K ﹤0.01% 1348

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Panagora Asset Management's TGTX Position: Q2 2025 in Review

Panagora Asset Management sold out of TG Therapeutics (TGTX) in Q2 2025, closing a stake of 30,044 shares — an estimated $1.18M sold.

Panagora Asset Management first reported a position in TGTX in Q2 2015 and held it in 12 quarters. The position peaked at $18.6M in Q1 2021. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.

  • Panagora Asset Management reported no remaining TG Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 30,044 TG Therapeutics shares in Q2 2025, an estimated $1.18M.
  • Panagora Asset Management first reported a position in TG Therapeutics in Q2 2015 and held it in 12 quarters.
  • Panagora Asset Management's TG Therapeutics position peaked at $18.6M in Q1 2021.
  • 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.